Lifecore Biomedical, Inc. (LFCR)
NASDAQ: LFCR · Real-Time Price · USD
5.61
-0.12 (-2.09%)
At close: Feb 21, 2025, 4:00 PM
5.71
+0.10 (1.78%)
After-hours: Feb 21, 2025, 7:08 PM EST
Lifecore Biomedical Market Cap
Lifecore Biomedical has a market cap or net worth of $207.71 million as of February 21, 2025. Its market cap has decreased by -8.78% in one year.
Market Cap
207.71M
Enterprise Value
329.60M
1-Year Change
-8.78%
Ranking
Category
Stock Price
$5.61
Market Cap Chart
Since December 1, 1998, Lifecore Biomedical's market cap has increased from $51.30M to $207.71M, an increase of 304.90%. That is a compound annual growth rate of 5.47%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Feb 21, 2025 | 207.70M | -9.54% |
Dec 31, 2024 | 229.60M | 22.32% |
Dec 29, 2023 | 187.70M | -2.14% |
Dec 30, 2022 | 191.80M | -41.35% |
Dec 31, 2021 | 327.00M | 3.06% |
Dec 31, 2020 | 317.30M | -3.76% |
Dec 31, 2019 | 329.70M | 0.33% |
Dec 31, 2018 | 328.60M | -5.19% |
Dec 29, 2017 | 346.60M | -7.79% |
Dec 30, 2016 | 375.90M | 17.62% |
Dec 31, 2015 | 319.60M | -13.85% |
Dec 31, 2014 | 371.00M | 15.58% |
Dec 31, 2013 | 321.00M | 31.29% |
Dec 31, 2012 | 244.50M | 70.98% |
Dec 30, 2011 | 143.00M | -9.55% |
Dec 31, 2010 | 158.10M | -3.89% |
Dec 31, 2009 | 164.50M | -4.47% |
Dec 31, 2008 | 172.20M | -50.66% |
Dec 31, 2007 | 349.00M | 29.79% |
Dec 29, 2006 | 268.90M | 42.50% |
Dec 30, 2005 | 188.70M | 18.75% |
Dec 31, 2004 | 158.90M | 13.58% |
Dec 31, 2003 | 139.90M | 261.50% |
Dec 31, 2002 | 38.70M | -36.87% |
Dec 31, 2001 | 61.30M | 35.92% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 784.71B |
UnitedHealth Group | 429.24B |
Novo Nordisk | 391.83B |
Johnson & Johnson | 390.76B |
AbbVie | 356.74B |
Abbott Laboratories | 234.01B |
AstraZeneca | 229.50B |
Merck & Co. | 226.40B |